In Quiet Debut, Alzheimer's Drug Rollout Slowed By Questions, Skepticism

Persistent concerns about Aduhelm, the disease's first new treatment in about 20 years, are curbing access more than four months after regulators approved it.

Source: Science - The Huffington Post - October 17, 2021 Category: Science Source Type: news